Skip to content
Esta página está disponible en españolCambiar →
GestorLensSign up

Novo Holdings A/s portfolio

Foundation or endowment
Follow Novo Holdings A/s
Share

Portfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 14, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Novo Holdings A/s reported a $1.7 bn portfolio of 25 positions to the SEC as of the end of Q2 2026. Its largest positions are EWTX, ASML, COAG. During the quarter it opened Floor & Decor Holdings and Alumis and exited Apogee Therapeutics and BioMarin Pharmaceutical.

Stock portfolio
$1.7 bn
Positions
25
Top 10: 73%
Turnover
26%
Copying its 13F, 5 years
—
Not calculated: not counted as a concentrated manager

Sections with a free account

What it reported after the quarter end (Q2 2026)

The 13F shows the portfolio as of Jun 30, 2026. Since then Novo Holdings A/s has filed these own trades with the SEC (Form 4, when it owns more than 10% of a company or holds a role in it) and stakes above 5% (13D and 13G). It is not everything it did: only what it must report before the next 13F.

What changed this quarter

17 positions with a change (4 new, 2 added to, 8 trimmed, 3 sold); also, 2 entered through an IPO. 10 are listed here: those of 0.5 points of the portfolio or more (up to 12).

It started trading this quarter: it appears in a 13F for the first time. The filing does not say whether the manager already held it before the listing, so it is not counted as a purchase.

The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.

Top holdings

“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.

Portfolio by sector

  • ● Health Care 72%
  • ● Information Technology 15%
  • ● Financials 9%
  • ● Consumer Discretionary 4%

How its portfolio changed (8 quarters)

Positions

Q2 2026: 25

370
Q3 2024Q2 2026
Top 10 weight

Q2 2026: 73%

74%69%
Q3 2024Q2 2026
Traded turnover

Q2 2026: 16.5%

16.7%0
Q3 2024Q2 2026

Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.

Stakes above 5% (13D/13G)

Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.

How we classify it

Not counted as a concentrated manager: it is a foundation or endowment; what it reports is usually donated stock or the direct slice of a portfolio run by others. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided

Managers of a similar size

A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.

Follow Novo Holdings A/s for free

When the next 13F is filed, we email you (if you turn it on) and it shows in your list. No credit card.

Follow Novo Holdings A/s